+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pediatric Vaccines Market Research Report by Technology, by Indication, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5124255
  • Report
  • September 2021
  • Region: United States
  • 89 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Pediatric Vaccines Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Pediatric Vaccines Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pediatric Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the Pediatric Vaccines Market was studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.
  • Based on Vaccine Type, the Pediatric Vaccines Market was studied across Monovalent and Multivalent.
  • Based on Indication, the Pediatric Vaccines Market was studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.
  • Based on End User, the Pediatric Vaccines Market was studied across Hospital, Pediatric Clinic, and Research Organization.
  • Based on State, the Pediatric Vaccines Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Pediatric Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Pediatric Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Pediatric Vaccines Market?
4. What is the competitive strategic window for opportunities in the United States Pediatric Vaccines Market?
5. What are the technology trends and regulatory frameworks in the United States Pediatric Vaccines Market?
6. What is the market share of the leading vendors in the United States Pediatric Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the United States Pediatric Vaccines Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Vaccine Type Outlook
3.5. Indication Outlook
3.6. End User Outlook
3.7. State Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Pediatric Vaccines Market, by Technology
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Monovalent
7.3. Multivalent

8. Pediatric Vaccines Market, by Indication
8.1. Introduction
8.2. Haemophilus Influenzae Type B
8.3. Hepatitis
8.4. Human papillomavirus (HPV)
8.5. Measles
8.6. Meningitis A
8.7. Mumps
8.8. Pneumococcal Diseases
8.9. Polio
8.10. Rotaviruses
8.11. Rubella
8.12. Tetanus
8.13. Yellow Fever

9. Pediatric Vaccines Market, by End User
9.1. Introduction
9.2. Hospital
9.3. Pediatric Clinic
9.4. Research Organization

10. California Pediatric Vaccines Market
10.1. Introduction

11. Florida Pediatric Vaccines Market
11.1. Introduction

12. Illinois Pediatric Vaccines Market
12.1. Introduction

13. New York Pediatric Vaccines Market
13.1. Introduction

14. Ohio Pediatric Vaccines Market
14.1. Introduction

15. Pennsylvania Pediatric Vaccines Market
15.1. Introduction

16. Texas Pediatric Vaccines Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 (USD MILLION)
FIGURE 4. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 5. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES PEDIATRIC VACCINES MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 10. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 12. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2026 (%)
FIGURE 27. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2026
FIGURE 29. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 34. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2026
FIGURE 36. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 38. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 40. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), 2018-2026 (USD MILLION)
FIGURE 41. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 42. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 44. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, 2018-2026 (USD MILLION)
FIGURE 45. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 46. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 48. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 50. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 52. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, 2018-2026 (USD MILLION)
FIGURE 55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 60. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 61. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2026
FIGURE 63. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 64. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 65. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2018-2026 (USD MILLION)
FIGURE 66. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 67. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, 2018-2026 (USD MILLION)
FIGURE 68. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 69. CALIFORNIA PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. FLORIDA PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. ILLINOIS PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. NEW YORK PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. OHIO PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. PENNSYLVANIA PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. TEXAS PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. UNITED STATES PEDIATRIC VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 77. UNITED STATES PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PEDIATRIC VACCINES MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES PEDIATRIC VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. CALIFORNIA PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. FLORIDA PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. ILLINOIS PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. NEW YORK PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. OHIO PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PENNSYLVANIA PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. TEXAS PEDIATRIC VACCINES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES PEDIATRIC VACCINES MARKET: SCORES
TABLE 40. UNITED STATES PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
TABLE 41. UNITED STATES PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
TABLE 42. UNITED STATES PEDIATRIC VACCINES MARKET: RANKING
TABLE 43. UNITED STATES PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 44. UNITED STATES PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
TABLE 45. UNITED STATES PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. UNITED STATES PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. UNITED STATES PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
TABLE 48. UNITED STATES PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. UNITED STATES PEDIATRIC VACCINES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll